Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for '3tc Hiv'

3tc Hiv published presentations and documents on DocSlides.

DTG/3TC 1st line (GEMINI)

DTG/3TC 1st line (GEMINI)

  • oryan
  • 37 Slides

ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...

Switch to PI/r + 3TC

Switch to PI/r + 3TC

  • lois-ondreau
  • 6 Slides

vs. PI/r . monotherapy. Study PIVOT. Study MOBID...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

  • jasmine
  • 15 Slides

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

DTG + 3TC versus DTG + TDF-FTC as Initial ART

DTG + 3TC versus DTG + TDF-FTC as Initial ART

  • della
  • 17 Slides

GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

  • jacey
  • 17 Slides

1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...

Switch to DRV/r + 3TC DUAL Study

Switch to DRV/r + 3TC DUAL Study

  • jireh
  • 9 Slides

DRV/r 800/100 + 3TC 300 QD. N = 126. N = 123. DRV/...

CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY

CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY

  • sophie
  • 22 Slides

Y. . S. un, J. Li, J. Ma, C. Wang, F. Bai, K. Zhao...

Switch to DTG/ABC/3TC

Switch to DTG/ABC/3TC

  • karlyn-bohler
  • 10 Slides

STRIIVING . Study. Design. Endpoints. Primary: pr...

Switch a ATV/r 3TC Estudio ATLAS-M

Switch a ATV/r 3TC Estudio ATLAS-M

  • pamella-moone
  • 0 Slides

ATV/r 300/100 mg QD 3TC 300 mg QD. N = 133. N =...

Switch to LPV/ r + 3TC OLE

Switch to LPV/ r + 3TC OLE

  • susan2
  • 6 Slides

Study. LPV/. r. bid + 3TC or FTC . qd. + NRTI. N ...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

  • lam
  • 10 Slides

Endpoints. Primary: proportion of patients with HI...

LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in

LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in

  • lucy
  • 7 Slides

Virologically. Suppressed. OLE Trial. LPV-RTV + ....

Switching to TDF-FTC from ABC-3TC for Hyperlipidemia

Switching to TDF-FTC from ABC-3TC for Hyperlipidemia

  • trinity
  • 6 Slides

ROCKET II. Switching to TDF-FTC from ABC-3TC . for...

EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC

EFV versus ATV + RTV, both with ABC-3TC or TDF-FTC

  • felicity
  • 8 Slides

ACTG 5202. EFV versus ATV/r, both with ABC-3TC or ...

Switch to DOR-TDF-3TC vs. Continued Baseline Regimen

Switch to DOR-TDF-3TC vs. Continued Baseline Regimen

  • dorothy
  • 8 Slides

DRIVE SHIFT. Switch to Doravirine-TDF-3TC versus C...

Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial

Switch from EFV plus ABC-3TC to EFV-TDF-FTC ROCKET-1 Trial

  • ricardo
  • 9 Slides

ROCKET-1 Trial. Switch from EFV + ABC-3TC to EFV-T...

ART Initiation in Resource-Limited Settings

ART Initiation in Resource-Limited Settings

  • lois-ondreau
  • 12 Slides

Susan M. Graham . Assistant Professor, Medicine a...

Treatment of Children and Adolescents

Treatment of Children and Adolescents

  • liane-varnes
  • 16 Slides

Implementation Challenges. Annette H. Sohn, MD. T...

Eric S. Daar , MD Professor of Medicine

Eric S. Daar , MD Professor of Medicine

  • faustina-dinatale
  • 0 Slides

David Geffen School of Medicine. at University of...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

  • myesha-ticknor
  • 0 Slides

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

Eric S. Daar , MD Professor of Medicine

Eric S. Daar , MD Professor of Medicine

  • faustina-dinatale
  • 0 Slides

David Geffen School of Medicine. at University of...

Antiretroviral Therapy (ART)

Antiretroviral Therapy (ART)

  • alexa-scheidler
  • 0 Slides

Dr. S . Ntshalintshali. Ngwelezana. hospital. N...

Interactive ART Cases From the Clinic: Is There One Right Answer?

Interactive ART Cases From the Clinic: Is There One Right Answer?

  • megan
  • 44 Slides

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

What’s new in the 2019 WHO Guidelines:

What’s new in the 2019 WHO Guidelines:

  • elina
  • 32 Slides

Dolutegravir based regimens in first- ad second-li...

ADDP Training Programme Community Retail Pharmacy Drug Distribution Points

ADDP Training Programme Community Retail Pharmacy Drug Distribution Points

  • jocelyn
  • 178 Slides

(CRPDDP). Training Contents. Module 1. : . HIV Ove...

HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO

HIV IN CHILDREN WHAT WE DO AS KENYA AND WHY WE DO

  • hazel
  • 59 Slides

Dr Laura Oyiengo. NATIONAL AIDS STI CONTROL PROGRA...

HIV/AIDS HIV There are two types of HIV virus HIV 1 and HIV 2 ,most cases are caused by type 1 ,t

HIV/AIDS HIV There are two types of HIV virus HIV 1 and HIV 2 ,most cases are caused by type 1 ,t

  • phoebe
  • 12 Slides

HIV1 and slower to progress to AIDS.. Most cases a...

Young person with multi-class resistance: follow-up and man

Young person with multi-class resistance: follow-up and man

  • luanne-stotts
  • 52 Slides

(with perspectives from well-resourced and resour...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 6 Slides

FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...

Treatment-Experienced Patients in Resource-Limited Settings

Treatment-Experienced Patients in Resource-Limited Settings

  • pasty-toler
  • 12 Slides

Susan M. Graham . Assistant Professor, Medicine a...

Fixed-Dose Combination of

Fixed-Dose Combination of

  • myesha-ticknor
  • 0 Slides

Doravirine. /Lamivudine/TDF is Non-Inferior to . ...

1 Fundación Huésped, Buenos Aires, Argentina;

1 Fundación Huésped, Buenos Aires, Argentina;

  • aaron
  • 0 Slides

2. Instituto Nacional de Ciencias Médicas y Nutr...

Missing formulations for paediatric HIV treatment and the Dakar Call for

Missing formulations for paediatric HIV treatment and the Dakar Call for

  • trish-goza
  • 0 Slides

Action. Improving Access to Optimized Treatment ....

Comparison of INSTI vs EFV

Comparison of INSTI vs EFV

  • mediumgeneral
  • 12 Slides

STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...

Meg Doherty MD MPH PhD 23 July 2018

Meg Doherty MD MPH PhD 23 July 2018

  • jordyn
  • 41 Slides

WHO HQ. The role of DTG based regimens in first- a...

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

  • audrey
  • 43 Slides

Dovato. ). Last Updated: November 28, 2022. Prepar...

HIV 2020: Time for change

HIV 2020: Time for change

  • garcia
  • 38 Slides

Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...

ClinicalTrials.gov

ClinicalTrials.gov

  • lauren
  • 13 Slides

Identifier: . NCT02770508 . Dual therapy based on ...

Cases from the Clinic(ians): Case-based Panel Discussion

Cases from the Clinic(ians): Case-based Panel Discussion

  • tripp
  • 15 Slides

Associate Dean for Global Health. University of Al...

Track B Workshop Controversies in the Management of HIV-positive Adults:

Track B Workshop Controversies in the Management of HIV-positive Adults:

  • natalia-silvester
  • 0 Slides

A Case-Based Approach. Sasisopin Kiertiburanakul,...

Copyright © 2024 DocSlides. All Rights Reserved